Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen vs. Indomethacin for Resistant PDA in Neonates
NCT01070745Phase 2Withdrawn
- Sponsor
- Shaare Zedek Medical Center
- Start
- Jun 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by Shaare Zedek Medical Center. Planned start Jun 2010; status: withdrawn.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT01070745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01070745.